Cardiovascular Diseases during Pregnancy

Pregnancy increases the risk of new-onset SVT. This risk is more in pregnant patients with Wolff-Parkinson-White syndrome. In the absence of structural heart disease, AF and atrial flutter are rare during pregnancy. Non-sustained ventricular arrhythmias takes place in up to 50% of pregnant women, but the clinical risk of sustained ventricular arrhythmia in the absence of structural heart disease is low.

Most antiarrhythmic drugs are divided as category C drugs while pregnancy by the United States Food and Drug Administration (FDA) .Therefore, drug therapy should be used only in patients who have life-threatening arrhythmias or debilitating symptoms. Most β-blockers are classified as category C drugs by the FDA; however, atenolol is classified as a category D drug because it has been implicated in intrauterine growth retardation, and sotalol, pindolol, and acebutolol are classified as category B drugs. The other class C drugs include digoxin, adenosine and heparin, whereas lidocaine and enoxaparin are class B drugs. Enoxaparin is safe for the fetus, but some formulations contain the preservative benzyl alcohol, which can be harmful. Amiodarone is taken as category D drug, and warfarin (category X) should not be used at all during pregnancy because of its teratogenicity.

    Related Conference of Cardiovascular Diseases during Pregnancy

    November 13-14, 2024

    12th International Conference on Hypertension and Healthcare

    Dubai, UAE
    November 25-26, 2024

    7th International Conference on Cardiovascular Diseases and Therapeutics

    Paris, France
    December 09-10, 2024

    3rd International Conference on Cardiology

    Dubai, UAE
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 12-13, 2024

    13th World Heart Congress

    Rome, Italy
    December 12-13, 2024

    5th Global Summit on Heart Congress

    Dubai, UAE
    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    February 24-25, 2025

    33rd International Conference on Cardiology and Cardiovascular Diseases

    London, UK
    February 27-28, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 23-24, 2025

    14th International Conference on Cardiology and Cardiovascular Medicine Research

    Paris, France
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    May 14-15, 2025

    6th International Conference on Cardiac Imaging and Diagnostics

    Barcelona, Spain
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    June 12-13, 2025

    12th International Conference on Interventional Cardiology

    London, UK
    June 19-20, 2025

    12th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

    Paris, France
    July 21-22, 2025

    33rd International Congress on Cardiology and Medical Interventions

    Toronto, Canada
    August 21-22, 2025

    34th International Conference on Clinical and Experimental Cardiology Research

    Vancouver, Canada
    October 22-23, 2025

    12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Aix-en-Provence, France

    Cardiovascular Diseases during Pregnancy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in